Edition:
United States

People: ZIOPHARM Oncology Inc (ZIOP.O)

ZIOP.O on Consolidated Issue listed on NASDAQ Capital Market

6.54USD
9 Dec 2016
Change (% chg)

$-0.05 (-0.76%)
Prev Close
$6.59
Open
$6.61
Day's High
$6.81
Day's Low
$6.36
Volume
2,572,553
Avg. Vol
1,906,151
52-wk High
$10.49
52-wk Low
$4.45

Cannon, James 

Mr. James A. Cannon is an Independent Director of ZIOPHARM Oncology, Inc. Mr. Cannon is currently Vice Chairman, Chief Financial Officer and a member of the board of directors of BBDO Worldwide, an advertising agency. In these capacities, he oversees the financial management of BBDO operations in 77 countries. Mr. Cannon joined BBDO in 1967, was promoted to Chief Financial Officer of the agency in 1984, and was elected to its board of directors one year later. An integral member of the team that formed Omnicom via a unique three-agency merger of BBDO, DDB and Needham Harper & Steers, Mr. Cannon became Comptroller of the new group (NYSE: OMC) and a member of its board of directors in 1986, a position he held through 2002. In 1987, he was appointed Director of Financial Operations of the Omnicom Group, serving in this capacity until early 1989 when he rejoined BBDO Worldwide as Executive Vice President and Chief Financial Officer. His return was concurrent with that of Allen Rosenshine who became Chairman and Chief Executive officer of BBDO after heading Omnicom. Mr. Cannon was promoted to Vice Chairman of the agency in 1990. Mr. Cannon is a graduate of Pace University and served in the U.S. Marine Corps.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --